News - Page 135 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article HAVN Life Successfully Exports Psilocybin from its Jamaica Facility into Canada

HAVN Life Successfully Exports Psilocybin from its Jamaica Facility into Canada

Post published:November 22, 2021
Post category:Press Release

Read more about the article PsyBio Therapeutics Furthers Intellectual Property Portfolio with Six New Manufacturing Patent Applications

PsyBio Therapeutics Furthers Intellectual Property Portfolio with Six New Manufacturing Patent Applications

Post published:November 19, 2021
Post category:Press Release

Read more about the article Psychedelic Bulletin: DEA Again Increases Psychedelics Production Quotas; MindMed Announces Microdosing Study; Shorter Trips?

Psychedelic Bulletin: DEA Again Increases Psychedelics Production Quotas; MindMed Announces Microdosing Study; Shorter Trips?

Post published:November 19, 2021
Post category:Psychedelic Bulletin

Read more about the article Numinus to Begin Trading on the OTC Under Symbol NUMIF

Numinus to Begin Trading on the OTC Under Symbol NUMIF

Post published:November 19, 2021
Post category:Press Release

Read more about the article Algernon Announces Positive Feedback on its Planned Phase 1/2a DMT Human Stroke Study

Algernon Announces Positive Feedback on its Planned Phase 1/2a DMT Human Stroke Study

Post published:November 19, 2021
Post category:Press Release

Read more about the article Wesana Health Clinics Surpass 4,000 Administered Ketamine Treatments

Wesana Health Clinics Surpass 4,000 Administered Ketamine Treatments

Post published:November 19, 2021
Post category:Press Release

Read more about the article Tryp Therapeutics Provides Update on Clinical Hold for Phase 2a Study for Eating Disorders

Tryp Therapeutics Provides Update on Clinical Hold for Phase 2a Study for Eating Disorders

Post published:November 18, 2021
Post category:Press Release

Read more about the article Filament Health Announces Co-Development and Exclusive Licensing Agreement with Entheotech Bioscience

Filament Health Announces Co-Development and Exclusive Licensing Agreement with Entheotech Bioscience

Post published:November 18, 2021
Post category:Press Release

Read more about the article MYND Diagnostics Commences Clinical Research on Multiple Sclerosis Biomarker Test

MYND Diagnostics Commences Clinical Research on Multiple Sclerosis Biomarker Test

Post published:November 18, 2021
Post category:Press Release

Read more about the article Small Pharma Strengthens Board With Appointment of Paul Maier as Independent Director

Small Pharma Strengthens Board With Appointment of Paul Maier as Independent Director

Post published:November 18, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.